Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients
Clinical trial NCT01990859 · COMPLETED
Trial details
- NCT number
- NCT01990859
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.